Company: INMB
Filing Date: 2025-05-09
Form Type: DEFR14A
Source: 0001213900-25-041516
Chunk: 6

Company: Inmune Bio, Inc.
Filing Date: 2025-05-09
Form: DEFR14A
Chunk 6
---
-------------|:--|-------------:|:----|:--|-------------:|
| Audit fees(1)         |              | $ |      418,261 |     | $ |      342,058 |
| Audit-related fees(2) |              |   |            — |     |   |            — |
| Tax fees(3)           |              |   |       23,304 |     |   |       22,402 |
| All other fees(4)     |              |   |            — |     |   |            — |
| Total fees            |              | $ |      441,565 |     | $ |      364,460 |

| (1) | Audit fees consist of fees incurred for professional services                                                                         
 rendered for the audit of consolidated financial statements, for reviews of our interim consolidated financial statements included in 
 our quarterly reports on Forms 10-Q and for services that are normally provided in connection with statutory or regulatory filings or 
 engagements. Includes professional services performed for filing of the Company’s registration statement on Form S-3 and for          
 the Company’s equity offerings.                                                                                                       |

| (2) | Audit-related fees consist of fees billed for professional                                                                           
 services that are reasonably related to the performance of the audit or review of our consolidated financial statements, but are not 
 reported under “Audit fees.”                                                                                                         |

| (3) | Tax fees consist of fees billed for professional services 
 relating to tax compliance, tax planning, and tax advice. |

| (4) | All other fees consist of fees billed for all other services. |

Audit Committee

The audit committee, among other things, is responsible
for:

| ● | Appointing, approving the compensation of, overseeing the                                            
 work of, and assessing the independence, qualifications, and performance of the independent auditor; |

| ● | reviewing the internal audit function, including its independence, 
 plans, and budget;                                                 |

| ● | approving, in advance, audit and any permissible non-audit 
 services performed by our independent auditor;             |

| ● | reviewing our internal controls with the independent auditor, 
 the internal auditor, and management;                         |

<div align='center'>4</div>

| ● | reviewing the adequacy of our accounting and financial controls               
 as reported by the independent auditor, the internal auditor, and management; |

| ● | overseeing our financial compliance system; and |

| ● | overseeing our major risk exposures regarding the Company’s                                                             
 accounting and financial reporting